New Frontiers and Old Tricks - Edinburgh Pharmacology Symposium
The Edinburgh Pharmacology Symposium 2016 will take place on Thursday 5th May.
REGISTRATION NOW OPEN AT: http://edin.ac/1Ue1umF
PROGRAMME
Opening Address: Professor JS Kelly
9.00-10.45am Session 1 - Small molecule modulation of gene expression
Chair: Professor Mark Evans
Plenary Lecture - Selective modulation of gene expression using bromodomain inhibitors
Dr Rab Prinjha, VP Head of Epigenetics DPU,
Immunoinflammation TA Unit, GSK Medicines Research Centre, Stevenage, UK.
Therapeutic potential of micro-RNA
Professor Andy Baker, BHF Professor of Translational, Cardiovascular Sciences,
Gustav Born Chair of Vascular Biology, Centre for Cardiovascular Science, University of Edinburgh.
Why target DNA modification reprogramming in cancer?
Professor Richard Meehan, Chromosomes and Gene Expression Programme Leader,
Institute of Genetics and Molecular Medicine, University of Edinburgh.
COFFEE
11.15-12.45pm Session 2 - Subunit- and subtype-selective modulation of enzymes and receptors: delivering cell and system specificity
Chair: Dr Christos Gkogas
Subunit-selective modulation of AMPK: from cell to system
Professor Mark Evans, Chair of Cellular Pharmacology,
Centre for Integrative Physiology, University of Edinburgh
Pharmacological modulation of 5alpha-reductase
Dr Dawn Livingstone, Lecturer,
Centre for Integrative Physiology, University of Edinburgh.
Enhanced analgesia from combined targeting of a receptor:channel signalling complex
Professor Sue Fleetwood-Walker, Chair of Sensory Neuroscience,
Centre for integrative Physiology, University of Edinburgh.
LUNCH
2.00-3.30pm Session 3 Overcoming barriers to innovation in academic drug discovery
Chair: Professor Michael Eddleston
Discovery of KMO inhibitors for potential treatment of organ failure
Dr Scott Webster, Senior Lecturer and Director of Drug Discovery Core,
Centre for Cardiovascular Science, University of Edinburgh
Targeting the Glycolytic Pathway for Trypanocidal Drugs
Prof Malcolm Walkinshaw, Chair of Structural Biochemistry and Director,
Centre for Translational and Chemical Biology, University of Edinburgh.
Scaffold hopping approaches to novel Autotaxin inhibitors
Dr Craig Jamieson, Senior Lecturer, Pure and Applied Chemistry,
University of Strathclyde, Glasgow, UK.
COFFEE
4.00-5.30pm Session 4 Pro-drugs and combinatorial therapies: tipping the balance towards a cancer cure
Chair: Dawn Livingstone
Novel Inhibitors of Tryptophan Metabolism as Cancer Immunotherapies
Dr Philip Cowley, Head of Chemistry, IOMET Pharma, Edinburgh, UK
Understanding resistance to cancer therapies
Professor Val Brunton, Chair of Cancer Therapeutics,
Centre for Cancer Therapeutics, University of Edinburgh
The role of tumour microenvironment in prostate cancer resistance to androgen deprivation therapy
Dr Binzhi Qian, Chancellor’s Fellow & CRUK Career Development Fellow
Edinburgh Cancer Research UK Centre & MRC University of Edinburgh Centre for Reproductive Health.
5.30-7pm Wine Reception
Registration and further information This event aims to provide a networking forum for research workers and clinicians with an interest in therapeutic developments and applications, by describing current projects and activities in the Edinburgh area.
It is supported by the University of Edinburgh and the British Pharmacological society ambassador scheme. Registration for this event is essential, the event is free of charge for undergraduates and PhD students and a nominal fee of £10 (Edinburgh staff) and £20 (External registrants) will be charged for participants.
Registration and payment is via University of Edinburgh ePay system: http://edin.ac/1Ue1umF
Further information
Please contact: